These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2052527)
41. Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. Sacco G; Bigioni M; Evangelista S; Goso C; Manzini S; Maggi CA Eur J Pharmacol; 2001 Feb; 414(1):71-8. PubMed ID: 11230997 [TBL] [Abstract][Full Text] [Related]
42. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186 [TBL] [Abstract][Full Text] [Related]
43. ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NOD mice. Bucci M; Roviezzo F; Brancaleone V; Di Lorenzo A; Evangelista S; Gori M; Cirino G Vascul Pharmacol; 2008; 49(2-3):84-90. PubMed ID: 18606247 [TBL] [Abstract][Full Text] [Related]
44. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog. Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554 [TBL] [Abstract][Full Text] [Related]
45. Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study. Borghi C; Cicero AF; Ambrosioni E Vasc Health Risk Manag; 2008; 4(3):665-71. PubMed ID: 18827916 [TBL] [Abstract][Full Text] [Related]
46. [ACE inhibitors after myocardial infarction: close-up on zofenopril]. Teyssedou A Ann Cardiol Angeiol (Paris); 2007 Jun; 56(3):137-44. PubMed ID: 17482555 [TBL] [Abstract][Full Text] [Related]
47. Zofenopril attenuates injury induced by ischemia-reperfusion on rat ovary. Keskin Kurt R; Dogan AC; Dogan M; Albayrak A; Kurt SN; Eren F; Silfeler DB; Karateke A; Fadillioglu E; Delibasi T J Obstet Gynaecol Res; 2015 Jun; 41(6):926-31. PubMed ID: 25546378 [TBL] [Abstract][Full Text] [Related]
48. An in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol. Shameem M; Imai T; Otagiri M J Pharm Pharmacol; 1993 Apr; 45(4):246-52. PubMed ID: 8098362 [TBL] [Abstract][Full Text] [Related]
49. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction. Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971 [TBL] [Abstract][Full Text] [Related]
50. Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies. Borghi C; Omboni S; Reggiardo G; Bacchelli S; Degli Esposti D; Ambrosioni E J Cardiovasc Pharmacol; 2017 Jan; 69(1):48-54. PubMed ID: 27798417 [TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats. Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037 [TBL] [Abstract][Full Text] [Related]
52. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition. Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA J Pharm Pharmacol; 2016 Nov; 68(11):1422-1429. PubMed ID: 27670145 [TBL] [Abstract][Full Text] [Related]
53. Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients. Borghi C; Omboni S; Novo S; Vinereanu D; Ambrosio G; Ambrosioni E; Cardiovasc Ther; 2016 Apr; 34(2):76-84. PubMed ID: 26789425 [TBL] [Abstract][Full Text] [Related]
54. Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography--mass spectrometry and its application to pharmacokinetic studies. Franklin ME; Addison RS; Baker PV; Hooper WD J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):47-54. PubMed ID: 9498669 [TBL] [Abstract][Full Text] [Related]
55. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ. Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113 [TBL] [Abstract][Full Text] [Related]
56. Metabolism of dopamine prodrug, docarpamine. Yoshikawa M; Nishiyama S; Takaiti O Hypertens Res; 1995 Jun; 18 Suppl 1():S211-3. PubMed ID: 8529066 [TBL] [Abstract][Full Text] [Related]
57. Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure. Kelbaek H; Agner E; Wroblewski H; Vasehus Madsen P; Marving J Eur Heart J; 1993 May; 14(5):692-5. PubMed ID: 8508863 [TBL] [Abstract][Full Text] [Related]
58. Prodrugs to improve the oral bioavailability of a diacidic nonpeptide angiotensin II antagonist. Aungst BJ; Blake JA; Rogers NJ; Saitoh H; Hussain MA; Ensinger CL; Pruitt JR Pharm Res; 1995 May; 12(5):763-7. PubMed ID: 7479565 [TBL] [Abstract][Full Text] [Related]
59. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial. Borghi C; Cicero AF; Bacchelli S; Esposti DD; Ambrosioni E; Fundam Clin Pharmacol; 2009 Oct; 23(5):641-8. PubMed ID: 19656211 [TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of RU44403, an active form of newly developed angiotensin-converting enzyme inhibitor (RU44570) in the rat. Hirayama M; Kurihara A; Manabe T; Hasegawa Y Drug Metab Dispos; 1994; 22(4):601-6. PubMed ID: 7956736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]